BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35906391)

  • 1. PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3.
    Zheng QW; Ni QZ; Zhu B; Liang X; Ma N; Wang YK; Xu S; Cao HJ; Xia J; Zhang FK; Zhang EB; Qiu XS; Ding XF; Qiu L; Zhang XL; Dong ZH; Li ZG; Zhang XL; Xie D; Li JJ
    Oncogene; 2022 Sep; 41(36):4244-4256. PubMed ID: 35906391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-6-phosphate dehydrogenase promotes the proliferation and migration of lung adenocarcinoma cells via the STAT3 signaling pathway.
    Wu W; Yu F; Yu N; Zhu Y; Wu W; Gao P; Chen C
    J Mol Histol; 2022 Apr; 53(2):215-225. PubMed ID: 35028787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STK11 mutation affects the killing effect of NK cells to promote the progression of lung adenocarcinoma.
    Huang Y; Zhang H; Feng J; Tang B
    APMIS; 2022 Nov; 130(11):647-656. PubMed ID: 35988018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of RNF183 suppressed proliferation of lung adenocarcinoma cells
    Ye G; Luo H; Zhang T; Lan T; Ling B; Qi Z
    Cell Cycle; 2022 May; 21(9):948-960. PubMed ID: 35104174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of deoxythymidylate kinase suppresses progression and epithelial-mesenchymal-transition of lung adenocarcinoma via STAT3 signaling.
    Yu F; Chen Y; Qiu R; Lin N; Yin Y; Zhuo Y; Lin J; Lai F
    Physiol Genomics; 2023 May; 55(5):213-221. PubMed ID: 36939206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling.
    Zhu P; Jin Z; Kang G; Jia Y; Liu D; Zhang Q; Guo F; Jia Y; Jiao Y; Li J; Sun H; Ma X
    Cell Commun Signal; 2022 Aug; 20(1):121. PubMed ID: 35971127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3.
    Liu L; Liu L; Lu S
    Int J Oncol; 2019 Mar; 54(3):929-941. PubMed ID: 30747209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3.
    Zhao X; Li X; Zhou L; Ni J; Yan W; Ma R; Wu J; Feng J; Chen P
    Cancer Sci; 2018 Oct; 109(10):3068-3079. PubMed ID: 30099826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
    Liu Z; Hu Z; Cai X; Liu S
    Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α5-nAChR/STAT3/CD47 axis contributed to nicotine-related lung adenocarcinoma progression and immune escape.
    Kang G; Jiao Y; Pan P; Fan H; Li Q; Li X; Li J; Wang Y; Jia Y; Wang J; Sun H; Ma X
    Carcinogenesis; 2023 Dec; 44(10-11):773-784. PubMed ID: 37681453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
    Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
    Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543.
    Xu Y; Lin L; Lv D; Yan S; He S; Ge H
    Tissue Cell; 2021 Oct; 72():101535. PubMed ID: 33892399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway.
    Huo SF; Shang WL; Yu M; Ren XP; Wen HX; Chai CY; Sun L; Hui K; Liu LH; Wei SH; Wang XX; Wang Y; Tian YX
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
    J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
    Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
    Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane progesterone receptor α (mPRα) enhances hypoxia-induced vascular endothelial growth factor secretion and angiogenesis in lung adenocarcinoma through STAT3 signaling.
    Xia Z; Xiao J; Dai Z; Chen Q
    J Transl Med; 2022 Feb; 20(1):72. PubMed ID: 35123491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPDPF Promotes the Progression and acts as an Antiapoptotic Protein in Non-Small Cell Lung Cancer.
    Yun M; Yingzi L; Jie G; Guanxin L; Zimei Z; Zhen C; Zhi L; Yingjie N; Lunquan S; Tao C; Yuezhen D; Chengzhi Z
    Int J Biol Sci; 2022; 18(1):214-228. PubMed ID: 34975328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress.
    Maryam A; Mehmood T; Zhang H; Li Y; Khan M; Ma T
    Sci Rep; 2017 Jul; 7(1):6242. PubMed ID: 28740138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway.
    Danni X; Jiangzheng Z; Huamao S; Yinglian P; Changcheng Y; Yanda L
    Bioengineered; 2021 Dec; 12(1):7335-7347. PubMed ID: 34612768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.